Stroke Clinical Trial
Official title:
Energy Consumption and Cardiorespiratory Load During Overground Gait Training With a Wearable Exoskeleton After Stroke: the Effect of the Level of Swing Assistance
Verified date | February 2019 |
Source | Vrije Universiteit Brussel |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
To investigate acute metabolic and cardiorespiratory responses during overground gait training with a wearable exoskeleton in persons after stroke
Status | Terminated |
Enrollment | 1 |
Est. completion date | December 31, 2018 |
Est. primary completion date | December 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 18 Years and older |
Eligibility |
Included will be persons who - Had a stroke - Cannot walk independently or can walk independently on level ground, but still require help on stairs, slopes or uneven surfaces (FAC 0 - 4) Excluded will be persons who - Can walk independently on level ground, stairs, slopes and uneven surfaces (FAC 5) - Have musculoskeletal problems (other than stroke) affecting the ability to walk - Have concurrent pulmonary diseases (e.g. asthma) - Have unstable cardiovascular conditions - Have concurrent neurological diseases (e.g. Parkinson's Disease) - Have communicative and/or cognitive problems affecting the ability to understand or follow instructions - Present contra-indications for using the Ekso GT (according to manufacturer's instructions) - Severe concurrent medical diseases (infections, circulatory, heart or lung, pressure sores) - Severe spasticity (Ashworth 4) - Range of motion restrictions that would prevent a patient from achieving normal, reciprocal gait pattern, or would restrict a patient from completing normal sit-to-stand or stand-to-sit transitions - Bilateral hip flexion < 110° - Knee flexion contracture > 12° - Inability to achieve 0° neutral angle dorsiflexion with knee flexion = 12° - Weight = 100 kg - Hip width < 35.8 cm or > 45.6 cm - Upper leg length < 51 cm or > 61.4 cm - Lower leg length < 48 cm or > 63.4 cm - Upper leg length discrepancy > 0.5 inch (1.3 cm) - Lower leg length discrepancy > 0.75 inch (1.9 cm) - Unstable spine, unhealed limbs or pelvic fractures - Unhealthy bone density - Heterotopic ossification - Significant contractures - Elbows and shoulders are unable to support crutches, walker or cane - Psychiatric or cognitive situations that may interfere with proper operation of the device |
Country | Name | City | State |
---|---|---|---|
Belgium | REVAlution center | Herentals | Antwerp |
Lead Sponsor | Collaborator |
---|---|
Vrije Universiteit Brussel |
Belgium,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Walking speed (m/min) at minute 5 of walking | The distance (meters) walked per minute | Minute 5 of 20-minute walking period | |
Other | Walking speed (m/min) at minute 10 of walking | The distance (meters) walked per minute | Minute 10 of 20-minute walking period | |
Other | Walking speed (m/min) at minute 15 of walking | The distance (meters) walked per minute | Minute 15 of 20-minute walking period | |
Other | Walking speed (m/min) at minute 20 of walking | The distance (meters) walked per minute | Minute 20 of 20-minute walking period | |
Primary | Net oxygen cost (OC, ml/kg/m) at minute 5 of walking | Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min) | Minute 5 of 20-minute walking period | |
Primary | Net oxygen cost (OC, ml/kg/m) at minute 10 of walking | Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min) | Minute 10 of 20-minute walking period | |
Primary | Net oxygen cost (OC, ml/kg/m) at minute 15 of walking | Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min) | Minute 15 of 20-minute walking period | |
Primary | Net oxygen cost (OC, ml/kg/m) at minute 20 of walking | Net oxygen consumption (oxygen consumption (ml/kg/min) during walking minus during rest) divided by the walking speed (m/min) | Minute 20 of 20-minute walking period | |
Primary | Net heart rate (HR, beats/min) at minute 5 of walking | Heart rate during walking (beats/min) minus resting heart rate | Minute 5 of 20-minute walking period | |
Primary | Net heart rate (HR, beats/min) at minute 10 of walking | Heart rate during walking (beats/min) minus resting heart rate | Minute 10 of 20-minute walking period | |
Primary | Net heart rate (HR, beats/min) at minute 15 of walking | Heart rate during walking (beats/min) minus resting heart rate | Minute 15 of 20-minute walking period | |
Primary | Net heart rate (HR, beats/min) at minute 20 of walking | Heart rate during walking (beats/min) minus resting heart rate | Minute 20 of 20-minute walking period | |
Primary | Net minute ventilation (VE, L/min) at minute 5 of walking | The amount of air in- or exhaled per minute (L/min) during walking minus during rest | Minute 5 of 20-minute walking period | |
Primary | Net minute ventilation (VE, L/min) at minute 10 of walking | The amount of air in- or exhaled per minute (L/min) during walking minus during rest | Minute 10 of 20-minute walking period | |
Primary | Net minute ventilation (VE, L/min) at minute 15 of walking | The amount of air in- or exhaled per minute (L/min) during walking minus during rest | Minute 15 of 20-minute walking period | |
Primary | Net minute ventilation (VE, L/min) at minute 20 of walking | The amount of air in- or exhaled per minute (L/min) during walking minus during rest | Minute 20 of 20-minute walking period | |
Secondary | Net Rating of Perceived Exertion (RPE, 6-20) at minute 5 of walking | Rating of perceived effort, strain and/or fatigue during walking, pointed on a 15-point Borg scale (6-20) during walking minus during rest | Minute 5 of 20-minute walking period | |
Secondary | Net Rating of Perceived Exertion (RPE, 6-20) at minute 10 of walking | Rating of perceived effort, strain and/or fatigue during walking, pointed on a 15-point Borg scale (6-20) during walking minus during rest | Minute 10 of 20-minute walking period | |
Secondary | Net Rating of Perceived Exertion (RPE, 6-20) at minute 15 of walking | Rating of perceived effort, strain and/or fatigue during walking, pointed on a 15-point Borg scale (6-20) during walking minus during rest | Minute 15 of 20-minute walking period | |
Secondary | Net Rating of Perceived Exertion (RPE, 6-20) at minute 20 of walking | Rating of perceived effort, strain and/or fatigue during walking, pointed on a 15-point Borg scale (6-20) during walking minus during rest | Minute 20 of 20-minute walking period | |
Secondary | Percentage maximal heart rate (%HRmax) at minute 5 of walking | Heart rate divided by predicted maximum heart rate. | Minute 5 of 20-minute walking period | |
Secondary | Percentage maximal heart rate (%HRmax) at minute 10 of walking | Heart rate divided by predicted maximum heart rate. | Minute 10 of 20-minute walking period | |
Secondary | Percentage maximal heart rate (%HRmax) at minute 15 of walking | Heart rate divided by predicted maximum heart rate. | Minute 15 of 20-minute walking period | |
Secondary | Percentage maximal heart rate (%HRmax) at minute 20 of walking | Heart rate divided by predicted maximum heart rate. | Minute 20 of 20-minute walking period | |
Secondary | Percentage heart rate reserve (%HRR) at minute 5 of walking | Heart rate during walking minus during rest divided by predicted heart rate reserve (i.e. predicted maximum heart rate minus resting heart rate) | Minute 5 of 20-minute walking period | |
Secondary | Percentage heart rate reserve (%HRR) at minute 10 of walking | Heart rate during walking minus during rest divided by predicted heart rate reserve (i.e. predicted maximum heart rate minus resting heart rate) | Minute 10 of 20-minute walking period | |
Secondary | Percentage heart rate reserve (%HRR) at minute 15 of walking | Heart rate during walking minus during rest divided by predicted heart rate reserve (i.e. predicted maximum heart rate minus resting heart rate) | Minute 15 of 20-minute walking period | |
Secondary | Percentage heart rate reserve (%HRR) at minute 20 of walking | Heart rate during walking minus during rest divided by predicted heart rate reserve (i.e. predicted maximum heart rate minus resting heart rate) | Minute 20 of 20-minute walking period | |
Secondary | Metabolic Equivalent of Task (MET) at minute 5 of walking | Expression of the intensity of walking defined as the oxygen consumption (ml/kg/min) during walking divided by the oxygen consumption (ml/kg/min) in rest | Minute 5 of 20-minute walking period | |
Secondary | Metabolic Equivalent of Task (MET) at minute 10 of walking | Expression of the intensity of walking defined as the oxygen consumption (ml/kg/min) during walking divided by the oxygen consumption (ml/kg/min) in rest | Minute 10 of 20-minute walking period | |
Secondary | Metabolic Equivalent of Task (MET) at minute 15 of walking | Expression of the intensity of walking defined as the oxygen consumption (ml/kg/min) during walking divided by the oxygen consumption (ml/kg/min) in rest | Minute 15 of 20-minute walking period | |
Secondary | Metabolic Equivalent of Task (MET) at minute 20 of walking | Expression of the intensity of walking defined as the oxygen consumption (ml/kg/min) during walking divided by the oxygen consumption (ml/kg/min) in rest | Minute 20 of 20-minute walking period |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT04043052 -
Mobile Technologies and Post-stroke Depression
|
N/A | |
Suspended |
NCT03869138 -
Alternative Therapies for Improving Physical Function in Individuals With Stroke
|
N/A | |
Completed |
NCT04101695 -
Hemodynamic Response of Anodal Transcranial Direct Current Stimulation Over the Cerebellar Hemisphere in Healthy Subjects
|
N/A | |
Completed |
NCT04034069 -
Effects of Priming Intermittent Theta Burst Stimulation on Upper Limb Motor Recovery After Stroke: A Randomized Controlled Trial
|
N/A | |
Terminated |
NCT03052712 -
Validation and Standardization of a Battery Evaluation of the Socio-emotional Functions in Various Neurological Pathologies
|
N/A | |
Completed |
NCT00391378 -
Cerebral Lesions and Outcome After Cardiac Surgery (CLOCS)
|
N/A | |
Recruiting |
NCT06204744 -
Home-based Arm and Hand Exercise Program for Stroke: A Multisite Trial
|
N/A | |
Active, not recruiting |
NCT06043167 -
Clinimetric Application of FOUR Scale as in Treatment and Rehabilitation of Patients With Acute Cerebral Injury
|
||
Enrolling by invitation |
NCT04535479 -
Dry Needling for Spasticity in Stroke
|
N/A | |
Completed |
NCT03985761 -
Utilizing Gaming Mechanics to Optimize Telerehabilitation Adherence in Persons With Stroke
|
N/A | |
Recruiting |
NCT00859885 -
International PFO Consortium
|
N/A | |
Recruiting |
NCT06034119 -
Effects of Voluntary Adjustments During Walking in Participants Post-stroke
|
N/A | |
Completed |
NCT03622411 -
Tablet-based Aphasia Therapy in the Chronic Phase
|
N/A | |
Completed |
NCT01662960 -
Visual Feedback Therapy for Treating Individuals With Hemiparesis Following Stroke
|
N/A | |
Recruiting |
NCT05854485 -
Robot-Aided Assessment and Rehabilitation of Upper Extremity Function After Stroke
|
N/A | |
Active, not recruiting |
NCT05520528 -
Impact of Group Participation on Adults With Aphasia
|
N/A | |
Active, not recruiting |
NCT03366129 -
Blood-Brain Barrier Disruption in People With White Matter Hyperintensities Who Have Had a Stroke
|
||
Completed |
NCT03281590 -
Stroke and Cerebrovascular Diseases Registry
|
||
Completed |
NCT05805748 -
Serious Game Therapy in Neglect Patients
|
N/A | |
Recruiting |
NCT05621980 -
Finger Movement Training After Stroke
|
N/A |